Search results
Results from the WOW.Com Content Network
In 1999, IBM withdrew as a part owner of IBA, while remaining its major business partner. In 2000, the IBA IT GmbH office opened in Düsseldorf, Germany. [7] In 2005, the head office of IBA Group was opened in Prague and at the same time IBA CZ office expanded to include a branch in Brno, Czech Republic. [8] In 2010, an office was opened in Astana.
IBA (Ion Beam Applications SA) is a medical technology company based in Louvain-la-Neuve. The company was founded in 1986 by Yves Jongen within the Cyclotron Research Center of the University of Louvain (UCLouvain) and became a university spin-off .
IBA has developed an affinity chromatography system for non-magnetic isolation of peripheral blood mononuclear cells, T cells, B cells and other cells of interest. This technology is known as Fab-TACS (Traceless Affinity Cell Selection) and is based on Strep-tagged Fab fragments, which reversibly capture and release the target cells.
Hetero group employs over 22,000 people. Hetero is a player in the active pharmaceutical ingredients market and finished dosages. [1] It has marketing presence in over 140 countries. Hetero has supplied antiretroviral drugs to patients across more than 100 countries globally. [2]
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.
Valeant Pharmaceuticals: Allergan, Inc: 45 58 Valeant Pharmaceuticals and activist investor Bill Ackman offered to buy Botox maker Allergan, proposing a cash-and-stock deal worth about $152.89. [31] 20 2014 Monsanto Company Inc. Syngenta AG: 40 51 Monsanto weighed $40 billion unsolicited bid for Swiss rival, Syngenta aiming to avoid US ...
In February 2022, Informa sold its Informa Pharma Intelligence unit to investment fund, Warburg Pincus for $2.6 billion. [33] Previous logo. It also sold Lloyd's List and EPFR to Montagu Private Equity in 2022. [34] In March 2023, in a cash and shares deal, Informa acquired the Irish Tarsus Group from Charterhouse Capital Partners for a ...
Valeant Pharmaceuticals: Milan Panić: Its original name was ICN Pharmaceuticals 1976: Teva Pharmaceutical Industries: Assia and Zori: Active 1982: SmithKline Beckman: SmithKline & French: Merge between SmithKline & French and Beckman Inc. 1993: Zeneca: Merger of the pharmaceuticals and agrochemicals businesses of Imperial Chemical Industries